|
Comparison of an automated cartridge-based system for mRNA assessment with central immunohistochemistry in the neoadjuvant GeparX trial. |
|
|
Stock and Other Ownership Interests - Sividon Diagnostics |
Honoraria - Amgen; Novartis; Pfizer; Roche; Teva |
Consulting or Advisory Role - Amgen; Daiichi Sankyo; MSD Oncology |
Patents, Royalties, Other Intellectual Property - EP20150702464 Patent application - therapy response; Patent application: EP18209672 - cancer immunotherapy; VMScope digital pathology software |
|
|
Honoraria - MSD; Novartis; Pfizer; Roche; Tesaro |
Consulting or Advisory Role - Amgen; Roche |
Travel, Accommodations, Expenses - Daiichi Sankyo; Pfizer; Pharma Marathi; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Novartis; Pfizer; Roche |
Speakers' Bureau - Celgene; Lilly; Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Amgen |
Travel, Accommodations, Expenses - Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst) |
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst) |
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst) |
|
|
Honoraria - Amgen; Amgen; AstraZeneca; MSD; Myriad Genetics; Novartis; Pfizer; Roche; SonoScape |
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD; Myriad Genetics; Novartis; Pfizer; Roche; SonoScape |